George Scangos' Bold Vision Post author:Sam Post published:October 24, 2017 Post category:BioPharma The former Biogen CEO is making waves at his new venture, Vir Biotechnology. Source: BioSpace You Might Also Like MacroGenics Announces Date Of First Quarter 2017 Financial Results Conference Call April 25, 2017 Bay Area's Pionyr Immunotherapeutics Scores $62M to Push Anti-Tumor Tech Towards Clinic December 12, 2017 NeuralStem Announces Pricing Of Public Offering Of Common Stock And Warrants July 26, 2017
Bay Area's Pionyr Immunotherapeutics Scores $62M to Push Anti-Tumor Tech Towards Clinic December 12, 2017
